First Trust Advisors LP Atri Cure, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$28.21 - $37.78 $251,097 - $336,279	-8,901 Reduced 34.26%	17,080 $519,000
Q4 2023 Feb 13, 2024	SELL	$32.99 - $43.25 $884,560 - $1.16 Million	-26,813 Reduced 50.79%	25,981 $927,000
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $1.87 Million - $2.62 Million	45,434 Added 617.31%	52,794 $2.31 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $701,189 - $860,014	-17,339 Reduced 70.2%	7,360 $363,000
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $619,618 - $815,678	17,274 Added 232.65%	24,699 $1.02 Million
Q4 2022 Feb 09, 2023	BUY	$33.48 - $47.45 $16,740 - $23,725	500 Added 7.22%	7,425 $329,000
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $1.01 Million - $1.39 Million	-26,434 Reduced 79.24%	6,925 $271,000
Q2 2022 Aug 12, 2022	BUY	$35.1 - $66.01 $443,277 - $833,640	12,629 Added 60.92%	33,359 $1.36 Million
Q1 2022 May 13, 2022	SELL	$57.43 - $71.39 $147,939 - $183,900	-2,576 Reduced 11.05%	20,730 $1.36 Million
Q4 2021 Feb 08, 2022	SELL	$63.4 - $87.14 $720,033 - $989,648	-11,357 Reduced 32.76%	23,306 $1.62 Million
Q3 2021 Nov 15, 2021	BUY	$69.28 - $84.46 $530,754 - $647,048	7,661 Added 28.37%	34,663 $2.41 Million
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $104,980 - $131,254	-1,637 Reduced 5.72%	27,002 $2.14 Million
Q1 2021 May 14, 2021	BUY	$53.79 - $66.98 $1.17 Million - $1.46 Million	21,840 Added 321.22%	28,639 $1.88 Million
Q4 2020 Feb 02, 2021	SELL	$34.56 - $57.55 $1.18 Million - $1.97 Million	-34,188 Reduced 83.41%	6,799 $379,000
Q3 2020 Nov 05, 2020	SELL	$38.36 - $46.91 $482,990 - $590,643	-12,591 Reduced 23.5%	40,987 $1.64 Million
Q2 2020 Jul 22, 2020	BUY	$31.78 - $51.19 $346,624 - $558,329	10,907 Added 25.56%	53,578 $2.41 Million
Q1 2020 May 06, 2020	BUY	$24.49 - $43.84 $731,320 - $1.31 Million	29,862 Added 233.13%	42,671 $1.43 Million
Q4 2019 Feb 03, 2020	SELL	$24.06 - $32.51 $601,355 - $812,554	-24,994 Reduced 66.12%	12,809 $416,000
Q3 2019 Nov 04, 2019	BUY	$23.81 - $32.52 $900,089 - $1.23 Million	37,803 New	37,803 $943,000
Q1 2019 May 09, 2019	SELL	$26.38 - $33.34 $365,996 - $462,559	-13,874 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$26.66 - $34.85 $369,880 - $483,508	13,874 New	13,874 $425,000
Q1 2018 Apr 23, 2018	SELL	$15.05 - $21.03 $769,024 - $1.07 Million	-51,098 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$17.69 - $23.44 $903,923 - $1.2 Million	51,098	51,098 $932,000

Others Institutions Holding ATRC

# of Institutions

211

Shares Held

49.6M

Call Options Held

12K

Put Options Held

7.2K

Vanguard Group Inc Valley Forge, PA

4.66M
Shares

$184 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$182 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

3.97M
Shares

$157 Million
0.04% of portfolio
Hood River Capital Management LLC Palm Beach Gardens, FL

2.83M
Shares

$112 Million
1.47% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.79M
Shares

$110 Million
0.5% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.83B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account